1367P - Treatment duration and adherence in ALK+ non-small cell lung cancer patients treated with brigatinib following prior ALK TKI therapy in the US
Brigatinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: 1367P - Treatment duration and adherence in ALK+ non-small cell lung cancer patients treated with brigatinib following prior ALK TKI therapy in the US ### Output: Brigatinib